Cite
GENE-22. CORRELATION BETWEEN PIK3R1MET326ILE MUTATION, CYSTEINE-RICH PROTEIN 61 EXPRESSION AND POOR PROGNOSIS IN GLIOBLASTOMA
MLA
Tetsuo Oka, et al. Gene-22. Correlation between Pik3r1met326ile Mutation, Cysteine-Rich Protein 61 Expression and Poor Prognosis in Glioblastoma. Nov. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c6e9b4522fdbd1faf63f6e89c36eb16&authtype=sso&custid=ns315887.
APA
Tetsuo Oka, Atsuhito Uneda, Yusuke Tomita, Joji Ishida, Isao Date, Hiroyuki Michiue, Tomotsugu Ichikawa, Yuji Matsumoto, Kazuhiko Kurozumi, Yoshihiro Otani, Yasuhiko Hattori, Toshihiko Shimizu, & Kentaro Fujii. (2017). Gene-22. Correlation between Pik3r1met326ile Mutation, Cysteine-Rich Protein 61 Expression and Poor Prognosis in Glioblastoma.
Chicago
Tetsuo Oka, Atsuhito Uneda, Yusuke Tomita, Joji Ishida, Isao Date, Hiroyuki Michiue, Tomotsugu Ichikawa, et al. 2017. “Gene-22. Correlation between Pik3r1met326ile Mutation, Cysteine-Rich Protein 61 Expression and Poor Prognosis in Glioblastoma,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c6e9b4522fdbd1faf63f6e89c36eb16&authtype=sso&custid=ns315887.